title: [Interaction of CN-100, a novel non-steroidal anti-inflammatory drug, on biopolymers].
abstract: Interaction of CN-100, a novel non-steroidal anti-inflammatory drug, with biopolymers were investigated. In collagen induced rat platelet aggregation, the inhibitory effect of CN-100 was almost equipotent as indomethacin (IM) but less potent than that of pranoprofen (PP). The effect of CN-100 on rat platelet aggregation induced by arachidonic acid (AA) was less potent than that of IM and PP. CN-100 inhibited rat platelet functions, serotonin release and malondialdehyde formation, induced by collagen more potently than those induced by AA. In heat-induced rat erythrocyte lysis and Ca2(+)-induced liposome aggregation, the inhibitory effect of CN-100 was less potent than IM but more than those of PP. CN-100 was inhibited with heat denaturation of BSA, and the effect was more potent than IM and PP. The metachromagy based on the binding of an azodye, HABA, to BSA was potentiated weakly by CN-100, but IM had no effect on it. CN-100 and IM increased the fluorescence of the binding of dansyl amide (site I probe) to BSA. These results support that there is considerable interaction between CN-100 and membrane protein, and this effect influences the membrane to increase its stability.
authors.affiliation: Central Research Laboratories, Zeria Pharmaceutical Co., Ltd., Saitama, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Kato
authors.forename: T
authors.initials: T
authors.lastname: Yoneta
authors.forename: A
authors.initials: A
authors.lastname: Yoshida
authors.forename: M
authors.initials: M
authors.lastname: Ozeki
authors.forename: E
authors.initials: E
authors.lastname: Tagashira
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000378:metabolism / Q000494:pharmacology*; D001578:Benzopyrans / Q000494:pharmacology; D001582:Benzothiepins / Q000378:metabolism / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D006461:Hemolysis / Q000187:drug effects; D007213:Indomethacin / Q000494:pharmacology; D008081:Liposomes; D008315:Malondialdehyde / Q000378:metabolism; D008565:Membrane Proteins / Q000378:metabolism / Q000502:physiology; D010974:Platelet Aggregation / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D011422:Propionates / Q000494:pharmacology; D011485:Protein Binding; D011489:Protein Denaturation / Q000187:drug effects; D012701:Serotonin / Q000378:metabolism
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D001578:Benzopyrans; D001582:Benzothiepins; D008081:Liposomes; D008565:Membrane Proteins; D010975:Platelet Aggregation Inhibitors; D011422:Propionates; C043940:pyranoprofen; D012701:Serotonin; D008315:Malondialdehyde; C051758:CN 100; D007213:Indomethacin